While Canadian drug maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced the return of Mike Pearson as CEO, biopharma firm Synergy Pharmaceuticals Inc (NASDAQ:SGYP) reported its …
Analyst Raghuram Selvaraju of Rodman & Renshaw is bullish on both Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Synergy Pharmaceuticals Inc (NASDAQ:SGYP), though for …
Both Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and OvaScience Inc (NASDAQ:OVAS) have been the source of investor concern. Valeant has been battling fraud allegations …
Healthcare analysts weigh in today on biotech companies Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Mast Therapeutics Inc (NYSEMKT:MSTX). The analysts positively viewed SGYP’s Plecanatide NDA submission, …
Healthcare analysts are out with commentary on biotech stocks Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and ZIOPHARM Oncology Inc. (NASDAQ:ZIOP).
In a research report released today, Rodman & Renshaw analyst Ram Selvaraju reiterated a Buy rating on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), with a …
In a research report released yesterday, Rodman & Renshaw analyst Ram Selvaraju initiated coverage on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), with a Buy rating and price …
In a research report released Wednesday, Rodman & Renshaw analyst Amit Dayal reiterated a Buy rating on Second Sight Medical Products Inc (NASDAQ:EYES) with …
